Clean Science and Technology Ltd - 543318 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Clean Science submitted the audio recording of its Q1 FY27 Earnings Conference Call, which took place on August 1, 2026. The recording for the quarter ended June 30, 2026, is now available on the company's website for investors.
Aug 01 2026 17:52:50
Clean Science and Technology Ltd - 543318 - Announcement under Regulation 30 (LODR)-Change in Directorate
Clean Science & Technology appointed Mr. Krishnakumar Satyanarain Saboo as an Additional Director, effective August 1, 2026. He is also recommended as a Whole-time Director for a 5-year term, subject to shareholder approval. This is a key leadership appointment.
Aug 01 2026 14:18:44
Clean Science and Technology Ltd - 543318 - Final Dividend Shall Be Paid To The Equity Shareholders Whose Name Appears In The Register Of Member Of The Company As On Saturday, 5Th September, 2026 Being Cut-Off Date/ Record Date Fixed For The Purpose.
Clean Science has fixed September 5, 2026, as the record date for its final dividend for FY2025-2026. The dividend will be paid on September 30, 2026, and the Register of Members will be closed from September 6-12, 2026.
Aug 01 2026 14:03:33
Clean Science and Technology Ltd - 543318 - Enclosed Is The Outcome Of Board Meeting
Clean Science & Technology appointed Krishnakumar Satyanarain Saboo as an Additional Director. The Board also recommended his appointment as Whole-time Director for a period of five years, effective August 1, 2026, due to his 37 years of experience.
Aug 01 2026 13:56:04
Clean Science and Technology Ltd - 543318 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Clean Science & Technology reported Q1 FY26 cons. revenue of ₹268.43 cr, a 10.5% increase YoY, with net profit rising 4.7% to ₹73.35 cr. The company also declared a final dividend, appointed Mr. Krishnakumar Saboo as Whole-time Director, and established a new wholly-owned subsidiary in the Netherlands.
Aug 01 2026 13:34:40
Clean Science and Technology Ltd - 543318 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Clean Science & Technology entered a strategic long-term supply arrangement with Kemin Industries. The company will serve as a substantial primary supplier of key ingredients for Kemin's food and feed industry for an initial term of five years. This aligns with the company's business strategy.
Aug 01 2026 11:06:53
Clean Science and Technology Ltd - 543318 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Clean Science & Technology's wholly-owned subsidiary, Clean-Fino Chem Ltd., received board approval to incorporate a step-down subsidiary in the Netherlands. This entity will focus on selling, distributing, and trading speciality chemicals, marking an international expansion.
Jul 30 2026 17:34:27
Clean Science and Technology Ltd - 543318 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Clean Science & Technology has scheduled an analyst and investor conference call on August 1, 2026, at 4:00 PM IST to discuss the unaudited financial results for the quarter ended June 30, 2026.
Jul 21 2026 11:44:11
Clean Science and Technology Ltd - 543318 - Board Meeting Intimation for Prior Intimation Of The Board Meeting To Consider Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2026.
Clean Science & Technology's Board of Directors will meet on August 1, 2026. The meeting's agenda is to consider and approve the company's Q1 FY27 financial results.
Jul 17 2026 11:58:30
Clean Science and Technology Ltd - 543318 - Intimation Regarding Clean-Fino Chem Limited -Wholly Owned Subsidiary Regarding Definitive Agreements For A Long-Term Strategic Collaboration With Geneus Chem AG, A Company Incorporated Under The Laws Of Switzerland.
Clean Science subsidiary Clean-Fino Chem collaborated with Swiss Geneus Chem AG for a long-term manufacturing and supply agreement of advanced HALS products. The subsidiary will also acquire a 25% equity stake in Geneus Chem AG upon warrant exercise, enhancing its specialty chemicals portfolio.
Jul 16 2026 18:59:39
Read More